This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Dr. Leo Liu, PhD
Principal Market Development Manager at Waters
Speaker

Profile

Leo obtained his Ph.D. from UCLA in biochemistry, where he designed synthetic enzyme systems capable of carbon fixation and production of useful biomaterials. After his Ph.D., he founded a startup company focused on making LNP (lipid nanoparticles) as a food additive backed by venture capitals such as the Hult Prize foundation. Later he joined Wyatt Technology in Santa Barbara as a senior scientist. Since late 2024, he moved to Singapore and he covers Wyatt light scattering portfolio for Waters APAC as a resident expert. He principally resides in Singapore while loves to travel to India, Japan, Korea and other ASEAN countries for leisure and business. He is able to speak broadly on biopharma and materials applications. Besides a passion for biopharma sciences, in his private life, he loves skiing, scuba diving, and photography.

Agenda Sessions

  • From Nucleotides to Genetic Vaccines, Journey the Mega-molecules with Waters CDMS and MALS

    10:20am